Although it is no longer pursuing the technology, Cambria Biosciences sees potential for an RNAi-based pest management method it developed a few years ago as a research tool, and is on the lookout for parties interested in out-licensing it, according to Scott Chouinard, director of molecular biology at Cambria.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.